Cangene Acquisition Of Hyal Supplants SkyePharma Deal
Executive Summary
Cangene will buy Hyal for approximately $200,000 more than SkyePharma offered for the Missisauga, Ontario-based drug delivery company. The SkyePharma agreement was expected to close July 30.